LINCOLN, NE
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)NEBRASKA HEART HOSPITAL, founded in 2011, is a mid-sized nonprofit that reported $76.7M in total revenue in fiscal year 2022. Revenue grew 12% year-over-year, indicating healthy expansion. Expenses of $69.0M left a modest 10% surplus.
AS AN AFFILIATE OF COMMONSPIRIT HEALTH, WE MAKE THE HEALING PRESENCE OF GOD KNOWN IN OUR WORLD BY IMPROVING THE HEALTH OF THE PEOPLE WE SERVE, ESPECIALLY THOSE WHO ARE VULNERABLE, WHILE WE ADVANCE SOCIAL JUSTICE FOR ALL.
THE NEBRASKA HEART HOSPITAL (NHH) PROVIDES A COMPREHENSIVE PROGRAM OF CARDIOLOGY SERVICES. THESE SERVICES BEGIN WITH THE PATIENT AND THEIR FAMILY PRACTICE OR PRIMARY CARE PHYSICIAN, A RELATIONSHIP...
THE NEBRASKA HEART HOSPITAL (NHH) PROVIDES A COMPREHENSIVE PROGRAM OF CARDIOLOGY SERVICES. THESE SERVICES BEGIN WITH THE PATIENT AND THEIR FAMILY PRACTICE OR PRIMARY CARE PHYSICIAN, A RELATIONSHIP FUNDAMENTAL IN THE PREVENTION AND TREATMENT OF HEART DISEASE. THE NEBRASKA HEART HOSPITAL PROVIDES AN INCLUSIVE SERIES OF NON-INVASIVE AND INVASIVE DIAGNOSTIC TESTING AND PRACTICES THE MOST UP-TO-DATE INTERVENTIONAL THERAPY IN THE TREATMENT OF HEART DISEASE. CARDIOLOGISTS AT THE NEBRASKA HEART HOSPITAL WORK WITH PATIENTS AND REFERRING PHYSICIANS TO ASSURE THAT A TEAM-BASED APPROACH IS USED FROM DIAGNOSIS THROUGH TREATMENT AND REHABILITATION.
SURGEONS WITH THE NEBRASKA HEART INSTITUTE PERFORM A VARIETY OF PROCEDURES TO TREAT CARDIAC, VASCULAR, AND THORACIC DISEASES. THESE SURGERIES INCLUDE BUT ARE NOT LIMITED TO: CORONARY ARTERY BYPASS...
SURGEONS WITH THE NEBRASKA HEART INSTITUTE PERFORM A VARIETY OF PROCEDURES TO TREAT CARDIAC, VASCULAR, AND THORACIC DISEASES. THESE SURGERIES INCLUDE BUT ARE NOT LIMITED TO: CORONARY ARTERY BYPASS, TAVR, TRANSMYOCARDIAL REVASCULARIZATION (TMR), VALVULAR PROCEDURES, TRANSPLANTATION, VASCULAR DISEASE, PERIPHERAL ANGIOGRAPHY, AND VEIN CLINIC.
DESPITE ADVANCES IN MEDICINE, HEART DISEASE REMAINS THE LEADING CAUSE OF DEATH IN THE UNITED STATES. THE NEBRASKA HEART HOSPITAL CARDIOVASCULAR HEALTH AND LIPID CLINIC IS COMMITTED TO WORKING TO...
DESPITE ADVANCES IN MEDICINE, HEART DISEASE REMAINS THE LEADING CAUSE OF DEATH IN THE UNITED STATES. THE NEBRASKA HEART HOSPITAL CARDIOVASCULAR HEALTH AND LIPID CLINIC IS COMMITTED TO WORKING TO PREVENT THE DEVELOPMENT AND PROGRESSION OF CORONARY AND VASCULAR DISEASE USING A HOLISTIC APPROACH INCLUDING RISK ASSESSMENT, LIFESTYLE CHANGES AND MEDICAL TREATMENT. A TEAM OF PHYSICIANS, ADVANCED PRACTICE CLINICIANS, NURSES AND DIETICIANS WORKS TO PROVIDE PERSONALIZED RISK ASSESSMENT AND A CUSTOMIZED PLAN TO DECREASE YOUR RISK OF DEVELOPING CARDIOVASCULAR DISEASE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2022 | 2021 | Change | |
|---|---|---|---|
| Revenue | $76,682,202 | $68,178,103 | +0.1% |
| Expenses | $68,992,180 | $59,063,674 | +0.2% |
| Net Income | $7,690,022 | $9,114,429 | -0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JOHN PETERSDORF | BOARD MEMBER | 1.00 |
Director
|
$0 | $677,245 | $3,026,445 |
| EVERT KUIPER | BOARD MEMBER/CEO CHI HEALTH | 1.00 |
Officer
Director
|
$0 | $29,391 | $1,303,984 |
| JEANETTE WOJTALEWICZ | CFO, CHI HEALTH (TERMED 1/6/23) | 5.00 |
Officer
|
$0 | $54,280 | $1,223,121 |
| DEREK VANCE | PRESIDENT (PARTIAL YEAR) | 25.00 |
Officer
|
$0 | $73,186 | $581,007 |
| KIRTIBALA GUPTA MD | BOARD MEMBER/PHYSICIAN | 1.00 |
Director
|
$0 | $44,314 | $440,317 |
| RICK THOMPSON | PRESIDENT | 25.00 |
Officer
|
$21,631 | $7,307 | $382,640 |
| HEATHER MORGAN MD | BOARD MEMBER/PHYSICIAN | 1.00 |
Director
|
$0 | $50,607 | $329,219 |
| NICK OTOOL | INTERIM CFO, CHI HEALTH | 1.00 |
Officer
|
$0 | $47,032 | $304,710 |
| EMILY MANNSCHRECK | PHARMACY DIRECTOR | 10.00 |
Highest
|
$49,111 | $43,375 | $242,377 |
| ANDREW BONNESS | PERFUSIONIST | 50.00 |
Highest
|
$189,507 | $42,405 | $231,912 |
| STEVE TYNDALL | MEDICAL DIRECTOR | 50.00 |
Highest
|
$201,640 | $24,327 | $225,967 |
| TIMOTHY LOEFFEL | PERFUSIONIST | 50.00 |
Highest
|
$198,640 | $39,315 | $244,784 |
| GERALD SCHWARZ | PERFUSION SUPERVISOR | 1.00 |
Highest
|
$4,008 | $39,797 | $235,718 |
| SISTER NADINE HEIMANN OSF | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SUSANNE L HRUZA MD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| SISTER MAURITA SOUKUP | BOARD CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| BILL YATES | VICE CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KENT BARNEY | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARDELL WILSON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KELLY BACON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| KEVIN FITZGERALD | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| LG SEARCEY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVE TAYLOR | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | No data | No data | No data | No data |
| 2023 | $76,682,202 | $68,992,180 | $205,943,790 | $7,690,022 |
| 2022 | $68,178,103 | $59,063,674 | $262,787,688 | $9,114,429 |
| 2021 | $65,185,418 | $57,263,730 | $249,037,406 | $7,921,688 |
| 2020 | $66,893,836 | $54,630,708 | $232,489,383 | $12,263,128 |
| 2019 | $70,288,203 | $58,402,434 | $192,096,712 | $11,885,769 |
| 2018 | $86,559,593 | $68,274,557 | $169,961,641 | $18,285,036 |
Compare NEBRASKA HEART HOSPITAL with other nonprofits in Nebraska and across the country.